# Q2 2026 corporate earnings announcements

> Live situation record from CLSTR: https://clstr.news/situations/20260728-q2-2026-corporate-earnings-announcements
> Updated: 2026-07-28T11:10:23.000Z. Sources: 7. Developments: 2.

In late July 2026, a series of Q2 earnings releases from banks and tech‑focused firms highlighted profit recovery. Columbia Banking System reported EPS $0.73, a 3.93% net interest margin and a loan portfolio of $47.2 bn with commercial loans up 9% quarter‑over‑quarter. Bancolombia posted normalized Q1 net income of COP 1.8 trillion and full‑year 2024 profit of COP 6.439 trillion, helped by higher net interest margins and lower loan‑loss provisions. Banco Latinoamericano de Comercio Exterior announced a dividend of $0.6875 per share, Q2 EPS $1.77, net margin 27.77% and revenue $98.90 million. Biogen’s Q2 2026 results showed revenue of $2.7 billion, a 3% year‑over‑year increase, while adjusted net income fell to $536 million ($3.60 per share). The company trimmed its full‑year EPS guidance to $12‑$13 and expects mid‑single‑digit revenue growth; its shares rose about 1.8% after the release, outpacing the S&P 500. An earnings call on July 29, 2026 featured CEO Christopher Viehbacher, CFO Robin Kramer and Head of Investor Relations Tim Power, confirming the figures and providing further guidance. Taboola’s projections remained at $0.05 EPS and $499.48 million revenue. Collectively, these disclosures illustrate the varied financial performance trends across banks and technology‑oriented companies in Q2 2026.

## Claims

- Biogen held its Q2 2026 earnings call on July 29, 2026, with CEO Christopher Viehbacher and CFO Robin Kramer participating. (corroborated by 2 sources)
- Biogen's Q2 2026 earnings call was held on July 29, 2026 at 8:30 AM EDT. (corroborated by 2 sources)
- Christopher Viehbacher was President, CEO & Director of Biogen during the Q2 2026 earnings call. (corroborated by 2 sources)
- Robin Kramer was Executive VP & CFO of Biogen during the Q2 2026 earnings call. (corroborated by 2 sources)
- Biogen reported Q2 2026 revenue of $2.7 billion, up 3% year‑over‑year. (single source)
- Biogen's adjusted net income for Q2 2026 was $536 million, or $3.60 per share, down from $803 million the previous year. (single source)
- Biogen's growth portfolio generated $1.06 billion in revenue, a 24% increase year‑over‑year. (single source)
- Biogen updated its full‑year guidance to expect revenue growth at a mid‑single‑digit rate in 2025. (single source)
- Biogen lowered its adjusted EPS guidance for the full year to $12‑$13 per share, from $14.25‑$15.25. (single source)
- Biogen's shares rose about 1.8% on the day, outperforming the S&P 500's 0.2% gain. (single source)
- Biogen's Q2 2026 revenue was $2.7 billion, up 3% year‑over‑year. (single source)
- Biogen's growth portfolio generated $1.06 billion in revenue, a 24% year‑over‑year increase. (single source)

## Timeline

### 2026-07-28: Biogen posts Q2 2026 revenue rise, shares jump 1.8%

Biogen Q2 2026 revenue hit $2.7 bn (+3%), growth portfolio $1.06 bn (+24%). Adjusted net income $536 m, EPS guidance cut to $12‑$13. Shares up 1.8%, call held July 29 2026.

6 sources. https://clstr.news/cluster/banco-latinoamericano-de-comercio-exterior-sets-quarterly-dividend-bluelinx-to-announce-earnings

### 2026-07-22: Columbia Banking System and Bancolombia Post Quarterly Earnings

Columbia Banking System posted Q2 EPS of $0.73 with a 3.93% net interest margin, while Bancolombia rebounded to a normalized Q1 2026 net income of COP 1.8 trillion, driven by higher margins and lower provisions

2 sources. https://clstr.news/cluster/columbia-banking-system-and-bancolombia-post-quarterly-earnings

---
Cite as: Q2 2026 corporate earnings announcements. CLSTR, https://clstr.news/situations/20260728-q2-2026-corporate-earnings-announcements